What Can Feminists Make of the Eugenicist History of Abortion?
By Erika Rodriguez,
Minnesota Women's Press
| 05. 24. 2023
In a footnote to the Dobbs v. Jackson decision that overturned Roe v. Wade last summer, Samuel Alito referenced an old right-wing talking point tying abortion advocacy to eugenics. He suggested that some pro-choice advocates were “motivated by a desire to suppress the size of the African American population,” and in dong so echoed Clarence Thomas’s 2019 concurrence in Box v. Planned Parenthood, which stated that abortion restrictions prevent “abortion from becoming a tool of modern-day eugenics.”
In the wake of the Dobbs ruling, many advocates denied the historical ties between abortion and eugenics. Yet the inconvenient fact remains that early 20th-century abortion rights were frequently articulated in relation to eugenic standards of “unfitness” and “racial betterment” in ways that remain relevant today. Although we may most frequently encounter this history through bad-faith arguments aimed at stripping away reproductive rights, feminists have a responsibility to grapple seriously with the ties between disability, abortion, and eugenics.
Pro-choice advocates have argued that the early abortion movement was directly opposed to eugenic practices (such as forced breeding or sterilization) because its focus was...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
